YOL046C Antibody

What is YOL046C Antibody and what organism does it target?

YOL046C Antibody is a research reagent designed to recognize and bind to the YOL046C protein encoded by the YOL046C gene in Saccharomyces cerevisiae (baker's yeast, specifically strain ATCC 204508 / S288c). The target protein is annotated under UniProt accession Q08216, though its precise biological function remains under active investigation within the yeast research community. As a primary antibody, it serves as an essential tool for detecting endogenous YOL046C protein in various experimental contexts requiring specific protein detection.

What applications is YOL046C Antibody validated for?

YOL046C Antibody has been validated for multiple standard laboratory applications including Western blot (WB), immunohistochemistry (IHC), immunofluorescence (IF), and immunoprecipitation (IP). The validation process typically employs knockout controls to confirm specificity, making this antibody suitable for both qualitative and quantitative research applications. When designing experiments, researchers should review the most current validation data from manufacturers to ensure appropriate application-specific performance.

How is YOL046C Antibody stored and what buffer conditions are optimal?

For optimal stability and performance, YOL046C Antibody is typically maintained in a buffer containing 50% glycerol and 0.01M phosphate-buffered saline (PBS) with 0.03% Proclin 300 as a preservative. This formulation helps maintain antibody integrity during freeze-thaw cycles. Researchers should store antibody aliquots at recommended temperatures (typically -20°C) and minimize repeated freeze-thaw cycles by preparing working aliquots. Buffer compatibility should be verified when designing experiments that may introduce alternative buffer components.

What controls are essential when working with YOL046C Antibody?

Proper experimental controls are critical for generating reliable data with YOL046C Antibody. Current best practices in antibody research emphasize using knockout (KO) controls as the gold standard for antibody validation . The following control scheme is recommended:

Recent research has shown that knockout controls are particularly superior to other validation methods for both Western blotting and immunofluorescence applications .

What are the optimal dilution ratios for different experimental applications?

Dilution optimization is essential for balancing signal strength and background. While exact dilutions should be determined empirically for each experimental system, the following starting points are recommended based on general antibody research practices:

Researchers should perform dilution series experiments when using a new lot of antibody or when applying the antibody to new experimental conditions.

How can YOL046C Antibody be effectively used for protein localization studies?

For subcellular localization studies, immunofluorescence microscopy with YOL046C Antibody can provide valuable insights. The following methodological approach is recommended:

• Fix yeast cells with 4% paraformaldehyde for 15-30 minutes, followed by spheroplasting with zymolyase to increase cell permeability

• Block with 1-3% BSA in PBS with 0.1% Triton X-100 for 30-60 minutes

• Incubate with primary YOL046C Antibody at optimized dilution (typically 1:100-1:500) overnight at 4°C

• Wash extensively (minimum 3x15 minutes) with PBS containing 0.1% Triton X-100

• Incubate with fluorophore-conjugated secondary antibody (1:500-1:1000) for 1-2 hours at room temperature

• Counterstain nuclei with DAPI and mount slides with anti-fade mounting medium

Critically, co-localization studies with established organelle markers can help define the specific subcellular distribution pattern. Recent literature indicates that knockout cell lines are particularly important for validating specificity in immunofluorescence applications, where background signal can be more problematic than in other techniques .

What approaches should be used for troubleshooting when YOL046C Antibody produces unexpected results?

When encountering unexpected results with YOL046C Antibody, a systematic troubleshooting approach should be implemented:

How can YOL046C Antibody be optimized for co-immunoprecipitation (Co-IP) studies?

Co-immunoprecipitation represents a powerful technique for investigating protein-protein interactions involving YOL046C. For optimal results, consider the following protocol refinements:

• Extract proteins under non-denaturing conditions using gentle lysis buffers (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate with protease inhibitors)

• Pre-clear lysates with protein A/G beads to reduce non-specific binding

• Incubate cleared lysates with 2-5 μg YOL046C Antibody per 500 μg protein overnight at 4°C with gentle rotation

• Add pre-equilibrated protein A/G beads and incubate for 2-4 hours at 4°C

• Wash extensively (minimum 4 times) with lysis buffer containing reduced detergent

• Elute bound proteins by boiling in SDS sample buffer or using gentler elution with 0.1 M glycine (pH 2.5)

• Analyze precipitated complexes by Western blot or mass spectrometry

When studying interaction partners, it's critical to include IgG isotype controls to identify non-specific binding. Crosslinking the antibody to beads using dimethyl pimelimidate (DMP) can prevent antibody contamination in subsequent analyses.

What considerations are important when using YOL046C Antibody for chromatin immunoprecipitation (ChIP)?

If YOL046C is suspected to interact with DNA or chromatin-associated proteins, ChIP can provide valuable insights:

• Cross-link yeast cells with 1% formaldehyde for 10-15 minutes at room temperature

• Quench with 125 mM glycine for 5 minutes

• Lyse cells and shear chromatin using sonication to achieve fragments of 200-500 bp

• Immunoprecipitate using 3-5 μg YOL046C Antibody per sample

• Reverse cross-links and purify DNA for analysis by qPCR or sequencing

The specificity of ChIP results should be validated using YOL046C knockout strains and IgG controls. Additionally, epitope accessibility may be affected by cross-linking, so optimization of fixation conditions is often necessary.

What are the best practices for quantitative Western blotting with YOL046C Antibody?

For reliable quantitative analysis of YOL046C protein levels:

• Ensure equal loading using total protein normalization (stain-free gels or reversible total protein stains) rather than relying solely on housekeeping proteins

• Use a standard curve of serially diluted positive control samples to confirm linearity of detection

• Operate within the linear dynamic range of both antibody binding and detection system

• Image using a digital system with appropriate dynamic range (avoid film)

• Analyze using software that can quantify band intensity relative to background

• Perform at least three biological replicates for statistical validation

Recent studies have demonstrated that recombinant antibodies generally outperform both monoclonal and polyclonal antibodies in quantitative assays, suggesting that recombinant versions of YOL046C Antibody would be preferable when available .

How should researchers address lot-to-lot variability when planning long-term studies?

Antibody lot-to-lot variability can significantly impact experimental reproducibility. Researchers conducting longitudinal studies should:

• Purchase sufficient quantities of a single, validated lot for critical studies

• Aliquot and store according to manufacturer recommendations to prevent freeze-thaw degradation

• Perform side-by-side validation when transitioning to new lots

• Maintain detailed records of antibody performance parameters for each lot

• Consider switching to recombinant antibody alternatives which offer improved consistency

Recent initiatives in antibody characterization have highlighted that approximately 20% of commercial antibodies fail to meet performance expectations, with vendors subsequently modifying recommended applications for approximately 40% of tested antibodies .

How can YOL046C Antibody be used in combination with mass spectrometry for protein complex analysis?

Integrating immunoprecipitation with mass spectrometry creates powerful opportunities for characterizing protein complexes:

• Perform immunoprecipitation using YOL046C Antibody with stringent washing steps

• Elute proteins under non-denaturing conditions using competitive elution with epitope peptides

• Separate proteins using SDS-PAGE or analyze directly by liquid chromatography

• Process samples for mass spectrometry using in-gel or in-solution digestion

• Analyze by LC-MS/MS to identify co-precipitating proteins

• Filter against datasets generated with IgG controls and from YOL046C knockout samples

For statistical robustness, perform at least three biological replicates and apply appropriate scoring algorithms to identify high-confidence interaction partners.

What approaches can be used to evaluate post-translational modifications of YOL046C?

Post-translational modifications (PTMs) can significantly impact protein function. To investigate PTMs of YOL046C:

• Immunoprecipitate native YOL046C protein using validated antibody

• Analyze by Western blot using modification-specific antibodies (phospho-, acetyl-, ubiquitin-, SUMO-specific)

• Employ 2D gel electrophoresis to separate protein isoforms

• Utilize mass spectrometry to identify specific modification sites

• Confirm functional significance through site-directed mutagenesis

Researchers should be aware that standard sample preparation protocols may not preserve all PTMs, and specialized approaches may be needed for specific modifications (e.g., phosphatase inhibitors for phosphorylation studies).

How might new antibody technologies improve YOL046C research?

Emerging technologies offer opportunities to enhance YOL046C research:

The development of recombinant antibody technologies is particularly promising, as studies have demonstrated they typically outperform traditional monoclonal and polyclonal antibodies across multiple applications .

What validation standards should be applied to YOL046C Antibody in light of the "antibody characterization crisis"?

In response to widespread concerns about antibody reliability, researchers should implement rigorous validation standards:

• Insist on knockout validation data when selecting commercial antibodies

• Perform independent validation even when using commercial antibodies with validation data

• Include appropriate controls in every experiment, especially knockout controls

• Share detailed methods including catalog numbers, lot numbers, and dilutions in publications

• Consider community resource initiatives like YCharOS that independently characterize antibodies

• Support the transition to recombinant antibodies that offer improved reproducibility

Recent studies found that approximately 12 publications per protein target included data from antibodies that failed to recognize their intended targets, highlighting the critical nature of proper validation .